ClinVar Miner

Submissions for variant NM_000253.3(MTTP):c.-214G>A

gnomAD frequency: 0.00066  dbSNP: rs569667113
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 6
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Illumina Laboratory Services, Illumina RCV000600514 SCV000446689 uncertain significance Abetalipoproteinaemia 2016-06-14 criteria provided, single submitter clinical testing
CeGaT Center for Human Genetics Tuebingen RCV001727699 SCV004153005 likely benign not provided 2023-03-01 criteria provided, single submitter clinical testing MTTP: BP4
PreventionGenetics, part of Exact Sciences RCV003902338 SCV004722971 likely benign MTTP-related condition 2019-07-18 criteria provided, single submitter clinical testing This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications).
Diagnostic Laboratory, Department of Genetics, University Medical Center Groningen RCV000600514 SCV000734296 likely benign Abetalipoproteinaemia no assertion criteria provided clinical testing
Clinical Genetics, Academic Medical Center RCV001700073 SCV001925389 benign not specified no assertion criteria provided clinical testing
Clinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center RCV001727699 SCV001969306 likely benign not provided no assertion criteria provided clinical testing

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.